QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Military families gain pharmacy choice; PBMs face cost floors and audits

S. 4106 — Rx ACCESS Act · Filed by Tom Cotton (R-AR) · 5 cosponsors · Introduced Mar 17, 2026 · Referred to committee

85%
Transparency
Typical bill: 85%
15/100
Hidden-provision risk
Typical bill: 15/100
Military Healthcare Access & Transparency

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill amends the TRICARE military pharmacy program to give beneficiaries more choice in how they receive maintenance medications starting October 1, 2026, and requires pharmacy benefit managers (PBMs) to reimburse retail pharmacies at rates tied to actual drug acquisition costs plus state Medicaid dispensing fees, with an annual audit by the Comptroller General to ensure compliance and adequate pharmacy network access.

Why we flagged it

The bill's core mechanism is restoring beneficiary choice in medication refill methods and imposing cost-based reimbursement floors on PBMs administering TRICARE pharmacy benefits, with mandatory audits. It is a consumer-protection and transparency measure within the military healthcare system, not a broad deregulation or carve-out.

What the text implies

  • The reimbursement floor tied to state Medicaid rates may create regional variation in pharmacy profitability, potentially affecting rural pharmacy participation if state Medicaid fees are low in certain regions.
  • Comptroller General audits are annual but non-binding; the bill does not specify enforcement mechanisms if audits reveal inadequate reimbursement or network gaps.
  • The restoration of beneficiary election (subparagraph D) applies only to 'non-generic prescription maintenance medications,' leaving generic maintenance drugs under prior rules—potential two-tier access.
  • PBM contracts must now include reimbursement floors and audit cooperation, but the bill does not address whether existing contracts are grandfathered or must be renegotiated.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Military beneficiaries and their families gain choice in medication refill methods and transparency into pharmacy reimbursement practices; retail pharmacies are protected from underpayment and hidden fees; independent audits ensure ongoing accountability. The reimbursement floor (actual cost + state Medicaid fee) prevents PBM margin-squeezing that would otherwise reduce pharmacy participation and access.

Who stands to gain

  • retail pharmacies (reimbursement floor protection)
  • independent and small-chain pharmacies (reduced PBM margin pressure)

Named in the bill

Department of Defense, TRICARE program, pharmacy benefit managers (PBMs), retail pharmacies, Comptroller General of the United States, Centers for Medicare & Medicaid Services (CMS), Senate Committee on Armed Services, House Committee on Armed Services

Where it stands

5 cosponsors: 2 Democrats, 2 Republicans, 1 Independents.

  • Mar 17, 2026 — Introduced · Congress.gov: “Introduced in Senate”
  • Mar 17, 2026 — Referred to Senate Committee on the Judiciary and Senate Committee on Armed Services · Congress.gov: “Read twice and referred to the Committee on the Judiciary”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

5 lobbying clients named this bill on 12 disclosure filings across 3 quarters, Mar 2026 to Sep 2026. Those filings disclosed $13,530,000 in lobbying spend. A filing names 24 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 74% of bills with at least one filing.

Tom Cotton, the sponsor, reported $1,378,306 in PAC receipts in the 2026 cycle. $10,000 of that came from 1 PAC tied to these lobbying clients.

  • Walmart Inc — $7,240,000 on 3 filings
  • The Cigna Group and Subsidiaries (formerly Cigna Corporation and Subsidiaries) — $3,490,000 on 1 filing
  • National Association of Chain Drug Stores — $1,090,000 on 3 filings
  • National Community Pharmacists Association — $960,000 on 3 filings
  • Kroger Co — $750,000 on 2 filings

Lobbying Disclosure Act filings through Oct 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.

How this was measured

Analysis — Quorum's AI read the bill text published by Congress.gov (3,847 characters) on Nov 14, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.

Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.

Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Mar 2026 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.

As of — lobbying records through Oct 21, 2026 · page rendered 2026-11-22.

“Military families gain pharmacy choice; PBMs face cost floors and audits” QuorumCivic. https://share.quorumcivic.app/bill/119/s4106 Report an error

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record

The week in bills

One email, Sunday: what Congress passed, what it changed, and who paid.

One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.